Medical professionals may need to puncture a lymph node for var10us medical procedures or applications, such as biopsies, lymphangiograms, or lymphatic interventions. However, puncturing a lymph node is very tricky due to the lymph structure's complex geometry and relatively thin walls. These complications make lymph node puncture access quite difficult for physicians or surgeons. Typically, medical professionals will use ultrasound guidance to first visualize the lymph nodes, and then the puncture needle will be guided into the lymph node structure. However, even with the assistance of ultrasound guidance, there is still a risk of over-perforation of the lymph node or loss of access given the ‘pancake’ or sinusoid shaped nature of the lymph node structure.
Thus, there is a significant medical need for a lymphatics puncture needle with a stabilization mechanism that not only ensures access to the lymph node, but also retention of that access while preventing over-perforation.
In one embodiment, a device for puncturing a lymph node comprises: a sleeve having a proximal portion and a distal portion and a lumen extending between the proximal and distal portions; an engagement catheter disposed within the lumen of the sleeve and having a proximal end and a distal end and a lumen extending between the proximal and distal ends; a flared stabilizer disposed at the distal end of the engagement catheter and flaring away from a center longitudinal axis of the engagement catheter, wherein the flared stabilizer is operably deployed by retraction of the sleeve toward its proximal portion; and a lymphatics puncture needle disposed within the lumen of the engagement catheter and operable to puncture a lymph node.
In one embodiment of a device for puncturing a lymph node, the flared stabilizer further comprises a plurality of flared tines extending outwardly from a center longitudinal axis of the flared stabilizer on the engagement catheter.
In one embodiment of a device for puncturing a lymph node, the plurality of flared tines comprises four axially cut tines.
In one embodiment of a device for puncturing a lymph node, the plurality of flared tines comprises tines extending 1-3 mm.
In one embodiment of a device for puncturing a lymph node, the lymphatics needle comprises a 23-25G distal to 21-22G proximal needle.
In one embodiment of a device for puncturing a lymph node, the lymphatic puncture needle is inserted 3-5 mm into the lymph node before the flared stabilizer contacts an outer wall surface of the lymph node, preventing over-perforation of the lymph node.
In one embodiment of a device for puncturing a lymph node, the lymphatics puncture needle has a length of 3-5 mm, distal to the flared stabilizer.
In one embodiment of a device for puncturing a lymph node, the lymphatics puncture needle is coated with a material to aid in ultrasound visualization.
In one embodiment, the invention comprises a method of puncturing a lymph node, comprising: advancing a lymphatic puncture needle toward a lymph node; retracing a sleeve to deploy a flared stabilizer; advancing the lymphatic puncture needle to puncture the lymph node, until the flared stabilizer stops against an outer wall surface of a lymph node; applying gentle pressure to the lymphatic needle to maintain a puncture site and stability without over-perforation of the lymph node.
In one embodiment of a method of puncturing a lymph node, the step of advancing the lymphatics puncture needle further comprises advancing the needle under ultrasound guidance.
In one embodiment of a method of puncturing a lymph node, the flared stabilizer further comprises a plurality of tines extending outwardly from a center longitudinal axis of the flared stabilizer.
In one embodiment of a method of puncturing a lymph node, the plurality of flared tines comprises four axially cut tines.
In one embodiment of a method of puncturing a lymph node, the step of retracting the sleeve comprises pulling the sleeve toward the operating physician.
In one embodiment of a method of puncturing a lymph node, advancing the lymphatic puncture needle comprises advancing the needle 3-5 mm, until the flared stabilizer stops against an outer wall surface of a lymph node to prevent over-perforation of the lymph node.
In one embodiment of a method of puncturing a lymph node, the step of retracting the sleeve comprises operating an actuator located on a handle of a catheter.
In one embodiment, a system for puncturing and stabilizing a lymph node, comprises: a sleeve having a proximal portion and a distal portion and a lumen extending between the proximal and distal portions; an engagement catheter disposed within the lumen of the sleeve and having a proximal end and a distal end and a lumen extending between the proximal and distal ends; a flared stabilizer disposed at the distal end of the engagement catheter and flaring away from a center longitudinal axis of the engagement catheter, a lymphatics puncture needle disposed within the lumen of the engagement catheter and operable to puncture a lymph node; and wherein the flared stabilizer is operably deployed by retraction of the sleeve toward its proximal portion to expose a plurality of flared tines which physically contact an outer wall surface of a lymph node to stop further advancement of the lymphatics needle to prevent over-perforation of the lymph node.
In one embodiment of a system for puncturing and stabilizing a lymph node, the plurality of flared tines comprises four axially cut tines.
In one embodiment of a system for puncturing and stabilizing a lymph node, the plurality of flared tines comprises tines extending 1-3 mm.
In one embodiment of a system for puncturing and stabilizing a lymph node, the lymphatics needle comprises a 23-25G distal to 21-22G proximal needle.
In one embodiment of a system for puncturing and stabilizing a lymph node, the lymphatic puncture needle is inserted 3-5 mm into the lymph node before the flared stabilizer contacts an outer wall surface of the lymph node, preventing over-perforation of the lymph node.
In one embodiment of a system for puncturing and stabilizing a lymph node, the lymphatics puncture needle has a length of 3-5 mm, distal to the flared stabilizer.
In one embodiment of a system for puncturing and stabilizing a lymph node, the lymphatics puncture needle has a contrast coating to aid visualization under ultrasound guidance.
The disclosed embodiments and other features, advantages, and disclosures contained herein, and the matter of attaining them, will become apparent and the present disclosure will be better understood by reference to the following description of various exemplary embodiments of the present disclosure taken in conjunction with the accompanying drawings, wherein:
As such, an overview of the features, functions and/or configurations of the components depicted in the various figures will now be presented. It should be appreciated that not all of the features of the components of the figures are necessarily described and some of these non-discussed features (as well as discussed features) are inherent from the figures themselves. Other non-discussed features may be inherent in component geometry and/or configuration. Furthermore, wherever feasible and convenient, like reference numerals are used in the figures and the description to refer to the same or like parts or steps. The figures are in a simplified form and not to precise scale.
For the purposes of promoting an understanding of the principles of the present disclosure, reference will now be made to the embodiments illustrated in the drawings, and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of this disclosure is thereby intended.
The present disclosure includes various engagement catheters 1810 having a lymphatics needle 1890 for puncture access and stabilization, and systems and methods for operating the engagement catheters to puncture a lymph node. Applicant also incorporates by reference herein, U.S. application Ser. No. 15/784,824 (U.S. Pub. No. 2018/0036514), and U.S. application Ser. No. 13/419,879 (U.S. Pub. No. 2012/0191180), both commonly owned herewith, for all that they disclose.
In a first embodiment, as shown in
The engagement catheter 1810 has a flared stopper or stabilizer portion 1830 at its distal end to stabilize the engagement catheter 1810 relative to the lymph node 1770 to be punctured and to limit the penetration depth of needle 1890, as shown in
The lymphatic puncture needle 1890 may be a hollow, tapered, needle having a size 23-25G distal to 21-22G proximal, and a distal portion of 3-5 mm in length, for example. The needle 1890 may be hollow for delivering or injecting pharmaceuticals or contrast dyes, and/or may also be used under, or in combination with, vacuum/suction procedures to take biopsy samples, for example. In other embodiments, the lymphatics puncture needle 1890 may also be coated with and/or be formed of a material to aid in, or improve, ultrasound visualization, brightness, and/or contrast.
In operation, the tapered lymphatics puncture needle 1890 (having a distal portion of 3-5 mm in length) may be inserted under ultrasound guidance to approach the lymph node 1770, as shown in
As shown in
The sleeve 1800 may be operated by a physician, using a handle portion or actuator portion located proximal to flared stopper or stabilizer 1830, to retract sleeve 1800 (in the direction of arrow 1860, as shown in
While various embodiments of devices and systems and methods for using the same have been described in considerable detail herein, the embodiments are merely offered as non-limiting examples of the disclosure described herein. It will therefore be understood that various changes and modifications may be made, and equivalents may be substituted for elements thereof, without departing from the scope of the present disclosure. The present disclosure is not intended to be exhaustive or limiting with respect to the content thereof.
Further, in describing representative embodiments, the present disclosure may have presented a method and/or a process as a particular sequence of steps. However, to the extent that the method or process does not rely on the particular order of steps set forth therein, the method or process should not be limited to the particular sequence of steps described, as other sequences of steps may be possible. Therefore, the particular order of the steps disclosed herein should not be construed as limitations of the present disclosure. In addition, disclosure directed to a method and/or process should not be limited to the performance of their steps in the order written. Such sequences may be varied and still remain within the scope of the present disclosure.
The present application is related to, claims the priority benefit of, and is a U.S. continuation patent application of, U.S. patent application Ser. No. 16/870,332, filed May 9, 2020, which is related to, and claims the priority benefit of, U.S. Provisional Patent Application Ser. No. 62/845,677, filed on May 9, 2019, the contents of which are hereby incorporated by reference in their entirety into this disclosure.
Number | Date | Country | |
---|---|---|---|
62845677 | May 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16870332 | May 2020 | US |
Child | 18439306 | US |